37 results on '"Jin, Shuiling"'
Search Results
2. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs
3. Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer
4. Accurate and portable tumor exosomes detection based on manganese dioxide and aptamer-functionalized fluorescent microspheres mediated dual-mode lateral flow assay
5. Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
6. Transcatheter arterial perfusion chemotherapy combined with lipiodol chemoembolization for advanced colorectal cancer complicated by obstruction
7. Histone lysine demethylase KDM5B facilitates proliferation and suppresses apoptosis in human acute myeloid leukemia cells through the miR-140-3p/BCL2 axis.
8. Thymosin alpha-1 blocks the accumulation of myeloid suppressor cells in NSCLC by inhibiting VEGF production
9. Detection and clinical significance of circulating tumor cells in colorectal cancer
10. Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
11. Myeloid-derived suppressor cells—new and exciting players in lung cancer
12. Updated results from the phase II study: Efficacy and safety of anlotinib plus sintilimab as second-line treatment for patients with advanced biliary tract cancers.
13. Long noncoding RNA DIO3OS interacts with miR-122 to promote proliferation and invasion of pancreatic cancer cells through upregulating ALDOA
14. A Quadruplex Ultrasensitive Immunoassay for Simultaneous Assessment of Human Reproductive Hormone Proteins in Multiple Biofluid Samples.
15. Feasibility and tolerability of sintilimab plus anlotinib as the second‐line therapy for patients with advanced biliary tract cancers: An open‐label, single‐arm, phase II clinical trial
16. Distinct clinical pattern of colorectal cancer patients with POLE mutations: A retrospective study on real-world data
17. Feasibility and tolerability of sintilimab plus anlotinib as the second‐line therapy for patients with advanced biliary tract cancers: An open‐label, single‐arm, phase II clinical trial.
18. Clinical Characteristics and Prognostic Values of PIK3CA Mutation in Colorectal Cancer Patients
19. Methylation of dual-specificity phosphatase 4 controls cell differentiation
20. Phase II study of anlotinib plus sintlimab as second-line treatment for patients with advanced biliary tract cancers.
21. LncRNA BC200 Promotes Esophageal Squamous Cell Cancer Migration and Invasion and Can Regulate ATF4 Expression
22. Abstract 35: Construction of ce-RNA networks and comprehensive analysis with tumor infiltrating immune cells in hepatocellular carcinoma
23. A Novel ALK Fusion Gene (NSF-ALK) Identified in a Patient With Recurrent Spindle Cell Sarcoma Respond to Crizotinib: A Case Report
24. A phase II study of anlotinib with cediranib as a second-line treatment for patients with advanced biliary tract cancers (aBTCs).
25. The genetic role of Glutathione S-Transferase Mu 3 (GSTM3) intron 6 polymorphism in the susceptibility to cancer
26. Nanoscale dual-enzyme cascade metal–organic frameworks through biomimetic mineralization as ROS generators for synergistic cancer therapy
27. PRMT1-RBM15 axis regulates megakaryocytic differentiation of human umbilical cord blood CD34+ cells
28. Transcatheter arterial chemoembolization with lipiodol for advanced gastric fundus and cardia cancer.
29. Splicing factor SF3B1K700E mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1
30. The TAL1 Short Isoform Generated By PRMT1-Mediated Alternative RNA Splicing Promotes Erythroid Differentiation
31. PRMT1‑RBM15 axis regulates megakaryocytic differentiation of human umbilical cord blood CD34+ cells.
32. Identification of Long Non-Coding RNA Genes Important for Normal Hematopoiesis and Leukemogenesis Using Bioinformatics Tools
33. Targeting PRMT1 As a Novel Curative Therapy for Acute Myeloid Leukemia
34. Splicing factor SF3B1K700E mutant dysregulates erythroid differentiation via aberrant alternative splicing of transcription factor TAL1.
35. PRMT1-RBM15 axis regulates megakaryocytic differentiation of human umbilical cord blood CD34 + cells.
36. MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.
37. Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.